64Cu-SAR-bisPSMA Trial for Prostate Cancer
Phase 3
220
about 1.6 years
18+
Male only
24 sites in AR, AZ, CA +15
What this study is about
Researchers are testing whether 64Cu-SAR-bisPSMA can help find prostate cancer that has returned after treatment. The trial will involve men with prostate cancer who have had previous treatments like surgery, radiation, or brachytherapy. Participants will be followed for about a year and a half.
Simplified from trial records by PatientMatch.
What you may be asked to do
- 1.Take 64Cu-SAR-bisPSMA
Participation Burden
What's physically and logistically required of participants.
Requires travel to a study site
How treatment is administered
Everyone gets the investigational treatment.
Extracted study details
Pulled from the trial record to show what is being tested and what the study is measuring.
Secondary: To determine the efficacy of 64Cu-SAR-bisPSMA PET/CT in participants with negative or equivocal conventional imaging at baseline, To investigate the safety and tolerability of 64-CuSAR-bisPSMA
Oncology